1921
  1. Home
  2. The American Journal of Tropical Medicine and Hygiene
  3. Volume 80, Issue 4
  4. Article
Volume 80, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
Download

Abstract

We evaluated the performance of the leishmanin skin test (LST) in 50 patients with visceral leishmaniasis (VL), 124 cured VL patients at different time intervals, 125 healthy controls from an endemic region (HEC), and 14 healthy controls from a non-endemic region (NEHC). The leishmanin antigen used was based on and was obtained from the Pasteur Institute (Iran). A positive LST was found in 14.0% of patients with active VL, 40.3% of cured patients, 21.6% of HECs, and 0% in NEHCs. The 14% positivity in patients with active VL conflicts with the widely held opinion that such patients should be negative because of anergy. Also, a lack of sensitivity of the LST was observed in cured VL patients. An LST antigen produced from strains from India should be explored.

Copyright 2009 The American Society of Tropical Medicine
Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2009.80.566
2009-04-01
2020-01-18

  • From This Site

    /content/journals/10.4269/ajtmh.2009.80.566
    dcterms_title,dcterms_subject,pub_keyword
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/14761645/80/4/0800566.html?itemId=/content/journals/10.4269/ajtmh.2009.80.566&mimeType=html&fmt=ahah

References

  1. Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD Jr, 1989. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 83 : 860–864. [Google Scholar]
  2. Khalil EAG, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM, 2005. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol 140 : 349–353. [Google Scholar]
  3. Desjeux P, 1992. Human leishmaniasis: epidemiology and public health aspects. World Health Stat Q 45 : 267–275. [Google Scholar]
  4. Sacks DL, Lal SL, Shrivastava SN, Blackwell JM, Neva FA, 1987. An analysis of T cell responsiveness in Indian Kala-azar. J Immunol 138 : 908–913. [Google Scholar]
  5. Zijlstra EE, El-Hassan AM, Ismail A, Ghalib HW, 1994. Endemic Kalaazar in eastern Sudan: a longitudinal study of the incidence of clinical and subclinical infection and post kala-azar dermal leishmaniasis. Am J Trop Med Hyg 51 : 826–836. [Google Scholar]
  6. Antunes CM, Mayrink W, Magalhaes PA, Costa CA, Melo MN, Dias M, Michalick MS, Williams P, Lima AO, Vieira JB, 1986. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int J Epidemiol 15 : 572–580. [Google Scholar]
  7. Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F, 2000. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomized, double-blind, BCG-controlled trial in Sudan. Lancet 356 : 1565–1569. [Google Scholar]
  8. Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Labaf-Ghasemi R, 1999. A randomized double-blind, controlled trial of killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine 17 : 466–472. [Google Scholar]
  9. Zhou XH, Obuchowski NA, McClish DK, 2002. Statistical Methods in Diagnostic Medicine. New York: Wiley & Sons.
  10. Sokal JE, 1975. Editorial: Measurement of delayed skin-test responses. N Engl J Med 293 : 501–502. [Google Scholar]
  11. Manson-Bahr PEC, 1961. Immunity in kala-azar. Trans R Soc Trop Med Hyg 55 : 550–555. [Google Scholar]
  12. el Safi S, Hamid N, Ahmad-Haleem OA, Hammad A, Kareem HG, Boelaert M, 2004. Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan. Trop Med Int Health 9 : 1305–1311. [Google Scholar]
  13. Bern C, Amann J, Haque R, Chowdhury AM, Kurkjian KM, Vaz L, Wagatsuma Y, Breiman RF, Secor WE, Maguire JH, 2006. Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh. Am J Trop Med Hyg 75 : 744–748. [Google Scholar]
  14. Mol CJ, Koethe SM, 2006. QuantiFERON TB GOLD: an innovation in tuberculosis screening. Aaohn J 54 : 245–247. [Google Scholar]
  15. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K, Kalantri S, 2006. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occupat Med Toxicol 1 : 7. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2009.80.566
Loading
Evaluation of Leishmanin Skin Test in Indian Visceral Leishmaniasis
The American Journal of Tropical Medicine and Hygiene 80, 566 (2009); https://doi.org/10.4269/ajtmh.2009.80.566
/content/journals/10.4269/ajtmh.2009.80.566
/content/journals/10.4269/ajtmh.2009.80.566
Loading

Data & Media loading...

  • Received : 12 Jun 2008
  • Accepted : 11 Nov 2008

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error